Skandinaviska Enskilda Banken (SEB)
EWTX icon

Skandinaviska Enskilda Banken (SEB)’s Edgewise Therapeutics EWTX Stock Holding History

Skandinaviska Enskilda Banken (SEB)’s Portfolio EWTX Stock Details EWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-37,591
Closed -$493K – 822
2025
Q2 		$493K Hold
37,591
– – ﹤0.01% 706
2025
Q1 		$827K Buy
+37,591
New +$986K ﹤0.01% 659

Other funds holding EWTX

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return

Skandinaviska Enskilda Banken (SEB)'s EWTX Position: Q3 2025 in Review

Skandinaviska Enskilda Banken (SEB) sold out of Edgewise Therapeutics (EWTX) in Q3 2025, closing a stake of 37,591 shares — an estimated $493K sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in EWTX in Q1 2025 and held it in 2 quarters. The position peaked at $827K in Q1 2025. 173 funds tracked by Wall St. Rank hold EWTX as of Q3 2025.

  • Skandinaviska Enskilda Banken (SEB) reported no remaining Edgewise Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Skandinaviska Enskilda Banken (SEB) sold 37,591 Edgewise Therapeutics shares in Q3 2025, an estimated $493K.
  • Skandinaviska Enskilda Banken (SEB) first reported a position in Edgewise Therapeutics in Q1 2025 and held it in 2 quarters.
  • Skandinaviska Enskilda Banken (SEB)'s Edgewise Therapeutics position peaked at $827K in Q1 2025.
  • 173 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q3 2025.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q3 2025, filed 7 Nov 2025.